Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2007-1-17
pubmed:abstractText
The anticonvulsant topiramate (TPM) has been recently proposed as a novel adjuvant therapy for bipolar disorder and schizophrenia, yet its efficacy remains controversial. As both disorders are characterized by gating deficits, we tested the effects of TPM on the behavioral paradigm of prepulse inhibition (PPI) of the acoustic startle response, a validated animal model of sensorimotor gating. TPM (10, 18, 32, 58, 100 mg/kg, intraperitoneal, i.p.) enhanced PPI in rats in a dose-dependent fashion, prevented the PPI reduction mediated by the dopaminergic agonist apomorphine (0.25 mg/kg, subcutaneous, s.c.) and potentiated the effects of the antipsychotic drugs haloperidol (0.05, 0.1 mg/kg, i.p.) and clozapine (2.5, 5 mg/kg, i.p.). Conversely, TPM elicited no significant effect on the PPI disruption mediated by the NMDA receptor antagonist dizocilpine (0.05, 0.1 mg/kg, s.c.) and surprisingly antagonized the attenuation of dizocilpine-induced PPI disruption mediated by clozapine (5 mg/kg, i.p.). Our results suggest that TPM may exert diverse actions on the neural substrates of sensorimotor gating. While the pharmacological mechanisms of such effects are still elusive, our findings might contribute to shed light on some controversies on the therapeutic action of TPM, and point to this drug as a putative novel adjuvant therapy for some clusters of gating disturbances.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0893-133X
pubmed:author
pubmed:issnType
Print
pubmed:volume
32
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
320-31
pubmed:dateRevised
2011-5-18
pubmed:meshHeading
pubmed-meshheading:16794573-Animals, pubmed-meshheading:16794573-Anticonvulsants, pubmed-meshheading:16794573-Antipsychotic Agents, pubmed-meshheading:16794573-Bipolar Disorder, pubmed-meshheading:16794573-Brain, pubmed-meshheading:16794573-Dopamine, pubmed-meshheading:16794573-Dopamine Agonists, pubmed-meshheading:16794573-Dose-Response Relationship, Drug, pubmed-meshheading:16794573-Drug Synergism, pubmed-meshheading:16794573-Excitatory Amino Acid Antagonists, pubmed-meshheading:16794573-Fructose, pubmed-meshheading:16794573-Glutamic Acid, pubmed-meshheading:16794573-Male, pubmed-meshheading:16794573-Neural Inhibition, pubmed-meshheading:16794573-Rats, pubmed-meshheading:16794573-Rats, Sprague-Dawley, pubmed-meshheading:16794573-Schizophrenia, pubmed-meshheading:16794573-Startle Reaction, pubmed-meshheading:16794573-Synaptic Transmission
pubmed:year
2007
pubmed:articleTitle
Effects of topiramate on the prepulse inhibition of the acoustic startle in rats.
pubmed:affiliation
Department of Neuroscience, Bernard B. Brodie, University of Cagliari, Cagliari, Italy.
pubmed:publicationType
Journal Article